Avandia may cause serious or even life-threatening heart problems
Two new studies suggest Avandia may cause serious heart problems. FDA will reveal on Friday the data it is reviewing ahead of an advisory panel meeting about the safety of the popular diabetes drug. The meeting, scheduled for July 13 and 14, comes on the heels of two new studies suggesting that Avandia may cause serious or [...]
Continue reading...12. June 2010
Blood pressure medications linked to increased risk of cancer
According to a study published in the British medical journal The Lancet Oncology, certain blood pressure medications may be linked to increased risk of cancer. The drugs in question are called angiotensin-receptor blockers or ARBs, AT1-receptor antagonists or sartans, are a group of pharmaceuticals which modulate the renin-angiotensin-aldosterone system. Their main use is in hypertension (high blood pressure), [...]
Continue reading...10. July 2010
Avandia may cause heart attacks
GlaxoSmithKline misinterpreted crucial details of a study finding that Avandia, its blockbuster diabetes drug, is safe, a medical reviewer for the Food and Drug Administration said Friday. Correctly interpreted, the study actually supports critics’ contentions that Avandia may cause heart attacks, said the reviewer, Dr. Thomas Marciniak, in a posting on the F.D.A.’s Web site. The company’s misreadings of the study, [...]
Continue reading...27. April 2010
Illegal marketing costs AstraZeneca $520 million
The settlement centers on the Delaware-based company’s efforts to promote Seroquel, which the Food and Drug Administration has approved to treat disorders such as schizophrenia and bipolar depression. The government alleges that AstraZeneca aggressively marketed the drug for unapproved uses — such as to treat Alzheimer’s disease and anxiety — to physicians, who then put [...]
Continue reading...9. November 2009
Wide Eye Schnapps Class Action Lawsuit
Wide Eye Schnapps FTC Decision & OrderFTC Enters Into Final Consent Agreement Regarding Product Claims The FTC entered a final consent agreement with Constellation Brands concerning the FTC’s charges that ads for Wide Eye caffeinated schnapps were deceptive. Wide Eye was a schnapps product containing 30 percent alcohol by volume. Ad claims included “Wake Up @WideEye.com,” [...]
Continue reading...20. January 2009
Avandia Drug Recall
Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came to [...]
Continue reading...
10. July 2010
0 Comments